Fig. 2From: Impact of C-reactive protein on the effect of Roxadustat for the treatment of anemia in chronic kidney disease: a systematic review of randomized controlled trialsRisk of bias assessment. A Risk of bias graph: review authors’ judgments about each risk of bias item presented as percentages across all included studies. B Risk of bias summary: review authors’ judgments about each risk of bias item for each included study. The items are scored ( +) low risk; (-) high risk; (?) some concernsBack to article page